Trinity Biotech Plc (TRIB)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Trinity Biotech Plc (TRIB) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011930
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Trinity Biotech Plc (Trinity Biotech) is a medical equipment company which develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The company’s product portfolio encompasses diagnostic tests and instruments that are used to detect haemoglobin A1c for diabetes monitoring and diagnosis, infectious diseases, autoimmune, sexually transmitted diseases, liver and intestine disorders. It also offers raw materials to research and life sciences sectors. Trinity Biotech markets its products through direct sales in the US, Germany, France and the UK; and through a network of distributors and strategic partnerships in other countries. The company has manufacturing facilities in the US and Ireland. Trinity Biotech is headquartered in Co. Wicklow, Ireland.

Trinity Biotech Plc (TRIB) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Trinity Biotech Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Trinity Biotech Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Trinity Biotech Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Trinity Biotech Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Trinity Biotech Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Trinity Biotech Plc, Medical Equipment, Deal Details 10
Asset Purchase 10
Trinity Biotech Acquires Blood Bank Screening Business Of Lab 21 For US$7.5 Million 10
Partnerships 11
Ginolis Enters into Partnership with Fiomi Diagnostics 11
Trinity Biotech Enters Into Distribution Agreement With A. Menarini Diagnostics 12
Debt Offering 13
Trinity Biotech Raises USD115 Million in Private Placement of Notes Due 2045 13
Acquisition 15
Trinity Biotech Acquires Immco Diagnostics For US$32.7 Million 15
Trinity Biotech Acquires Fiomi Diagnostics For US$13 Million 16
Trinity Biotech Acquires Phoenix Bio-Tech 17
Trinity Biotech Plc – Key Competitors 18
Trinity Biotech Plc – Key Employees 19
Trinity Biotech Plc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Financial Announcements 22
Oct 26, 2017: Trinity Biotech Announces Results for Q3, 2017 22
Jul 20, 2017: Trinity Biotech Announces Results for Q2, 2017 24
Apr 27, 2017: Trinity Biotech Announces Results for Q1, 2017 26
Mar 14, 2017: Trinity Biotech announces Quarter 4 and Fiscal Year 2016 Financial Results 27
Oct 25, 2016: Trinity Biotech announces Quarter 3 Financial Results 29
Jul 21, 2016: Trinity Biotech Announces Quarter 2 Financial Results 31
Apr 19, 2016: Trinity Biotech Announces Results for Q1, 2016 33
Mar 03, 2016: Trinity Biotech Announces Results for Q4 and Fiscal Year 2015 35
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Trinity Biotech Plc, Medical Equipment, Key Facts, 2016 2
Trinity Biotech Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Trinity Biotech Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Trinity Biotech Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Trinity Biotech Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Trinity Biotech Plc, Deals By Market, 2011 to YTD 2017 8
Trinity Biotech Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Trinity Biotech Acquires Blood Bank Screening Business Of Lab 21 For US$7.5 Million 10
Ginolis Enters into Partnership with Fiomi Diagnostics 11
Trinity Biotech Enters Into Distribution Agreement With A. Menarini Diagnostics 12
Trinity Biotech Raises USD115 Million in Private Placement of Notes Due 2045 13
Trinity Biotech Acquires Immco Diagnostics For US$32.7 Million 15
Trinity Biotech Acquires Fiomi Diagnostics For US$13 Million 16
Trinity Biotech Acquires Phoenix Bio-Tech 17
Trinity Biotech Plc, Key Competitors 18
Trinity Biotech Plc, Key Employees 19
Trinity Biotech Plc, Subsidiaries 20

★海外企業調査レポート[Trinity Biotech Plc (TRIB)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Goldman Sachs Group Inc (GS):企業の財務・戦略的SWOT分析
    The Goldman Sachs Group Inc (GS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Southern Travel Holdings Limited:企業の戦略・SWOT・財務分析
    Southern Travel Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Southern Travel Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Chevron Corp (CVX):電力:M&Aディール及び事業提携情報
    Summary Chevron Corp (Chevron) is an integrated oil and gas company. It operates in the oil and gas value chain from exploration and production, storage and pipeline transportation to refining, marketing and distribution of oil and gas products. Chevron explores for, produces and transports crude oi …
  • Mostostal Warszawa SA (MSW):企業の財務・戦略的SWOT分析
    Mostostal Warszawa SA (MSW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Trevena Inc (TRVN)-製薬・医療分野:企業M&A・提携分析
    Summary Trevena Inc (Trevena) is a biopharmaceutical company that discovers and develops G-protein coupled receptor targeted medicines. The company’s products include RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination with …
  • SAES Getters S.p.A. (SG):企業の財務・戦略的SWOT分析
    SAES Getters S.p.A. (SG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Tsakos Energy Navigation Ltd (TNP):石油・ガス:M&Aディール及び事業提携情報
    Summary Tsakos Energy Navigation Ltd (TEN), a subsidiary of Tsakos Group, is a marine transportation company that provides transportation services of crude oil, petroleum products and liquefied natural gas (LNG) to national and international oil companies and refineries. It charges customer on time …
  • Fujifilm Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Fujifilm Corp (Fujifilm), a subsidiary of Fujifilm Holdings Corporation, is a provider of imaging and information solutions. The company’s product portfolio encompasses color films, optical devices, digital cameras, photofinishing equipment and color paper, chemicals and services for photofi …
  • The Boeing Co (BA):企業の財務・戦略的SWOT分析
    The Boeing Co (BA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Connect Group PLC (CNCT):企業の財務・戦略的SWOT分析
    Connect Group PLC (CNCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Investors Heritage Capital Corporation:企業の戦略・SWOT・財務情報
    Investors Heritage Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary Investors Heritage Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Genexine Inc (095700):製薬・医療:M&Aディール及び事業提携情報
    Summary Genexine Inc (Genexine), formerly Genexine Co Ltd is a clinical stage biotechnology company that develops and commercialize immunotherapeutics and next generation novel long-acting biologics. The company develops therapeutic vaccines for incurable diseases and next-generation antibody fusion …
  • Pakistan Oxygen Limited (LINDE):企業の財務・戦略的SWOT分析
    Pakistan Oxygen Limited (LINDE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • PartnerRe Ltd.:企業の戦略・SWOT・財務情報
    PartnerRe Ltd. - Strategy, SWOT and Corporate Finance Report Summary PartnerRe Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Bankinter Banca Privada:企業の戦略・SWOT・財務情報
    Bankinter Banca Privada - Strategy, SWOT and Corporate Finance Report Summary Bankinter Banca Privada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Arab Bank (Switzerland) Ltd.:企業の戦略・SWOT・財務情報
    Arab Bank (Switzerland) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Arab Bank (Switzerland) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Valeo S.A.:企業の戦略・SWOT・財務情報
    Valeo S.A. - Strategy, SWOT and Corporate Finance Report Summary Valeo S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • RCS MediaGroup S.p.A. (RCS):企業の財務・戦略的SWOT分析
    RCS MediaGroup S.p.A. (RCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Kresta Holdings Limited (KRS):企業の財務・戦略的SWOT分析
    Kresta Holdings Limited (KRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Iridex Corp (IRIX):企業の財務・戦略的SWOT分析
    Summary Iridex Corp (Iridex) is a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company offers products such as lasers, laser delivery devices, glaucoma device …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆